CMI Communications
Издатель: Elsevier · ISSN 2950-5909 · 36 статей
- Metagonimus yokogawai: A Fluke, Not by Chance — Yokogawa’s Lasting Impact
- More than just a urinary tract infection: the impact of the vaginal microbiome on urogenital health
- Management of community-acquired pneumonia in adults: Practice Guideline from The Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians
- Time to acyclovir and outcome of varicella zoster virus encephalitis: A prospective population-based cohort study
- Direct detection of Trichosporon asahii in blood using a quantitative polymerase chain reaction assay: development and validation in spiked samples
- Appropriateness of antibiotic use for individuals >65 years of age: A population-wide analysis
- Impact of blood culture bottle shortage on blood culture positivity rates in Japan: a nationwide hospital-based study
- A proof-of-concept performance evaluation of six large language models for semiautomated data extraction in a systematic review on infectious diseases clinical trials
- Vaginal dysbiosis is associated with urinary symptoms and urinary tract infection: A case–control study
- Corrigendum to “Standing on the shoulders of Edward H. Kass” [CMI Communications volume 2 issue 3 (2025) Article number 105098]
- The forgotten Canetti: Mycobacterium canettii and the origins of tuberculosis
- What’s in a name? The rise of Klebsiella pneumoniae: from Friedländer to Klebs
- European Respiratory Society/European Society of Clinical Microbiology and Infectious Diseases state-of-the-science statement on the role of rapid diagnostic tests for the diagnosis and management of community-acquired lower respiratory tract infections
- Communicable episode 46: Steroids for pneumocystis pneumonia
- Communicable episode 42: Should doctors stay at X (Twitter) or leave it?
- Communicable episode 44: Top clinical microbiology papers in 2025
- Communicable episode 45: top infectious diseases papers in 2025
- Communicable episode 47: Drawing the line—the writing, reach, and limits of guidelines
- Communicable episode 52: ESCMID Global Trials – PETER PEN and ASTARTÉ
- Should science and scientists explicitly repudiate war? An ESCMID Study Group for Infections in Travellers and Migrants (ESGITM) proposal to expand ethical declarations in scientific publishing
- Corrigendum regarding previously published articles
- Science, not politics: the ESCMID view on protecting populations against measles, mumps and rubella
- Duration of Therapy for Bacteremic Cardiac Implantable Electronic Device Infections
- Who actually needs antibiotics for pneumonia? Rethinking diagnosis in the era of molecular diagnostics and bedside imaging
- Prevention and Management of Urinary Tract Infections in Kidney Transplant Recipients: a narrative review
- Erratum 26 October 2026
- In Vitro Activity of Cefiderocol Against Carbapenemase-Producing Escherichia coli: Correlating Phenotypic and Genomic Resistance
- You can’t exclude what was never included: A proposal to standardize the formulation of trial eligibility criteria and CONSORT accounting of excluded participants
- Reduced chlorhexidine susceptibility in multidrug-resistant Klebsiella pneumoniae; genomic and functional analysis of invasive isolates
- Eritoran and apremilast in hospitalized patients with COVID-19: The REMAP-CAP immune modulation-2 domain